Flamel Technologies is a leading drug delivery company which has leveraged its expertise in polymer chemistry to create two best-in-class platforms: Medusa for the delivery of large and small molecule drugs via subcutaneous injection or intravenously; and Micropump for the delivery of small molecule drugs best absorbed in the small intestine. Both technologies may be used to create formulations with better safety and efficacy. The platforms also may be used to solve threshold issues in drug development such as poor solubility; aggregation; and poor stability. The Company has assembled a strong team of researchers expert in polymer science and biochemistry, and owns cGMP pharmaceutical production facility of over 100,000 square feet located in Pessac, France. The facility is the sole source manufacturer for Coreg CR® microparticles, which the Company produces for GlaxoSmithKline. GSK licensed the Micropump platform and worked to develop Coreg CR with Flamel.

Flamel's business model is to work in partnership with leading pharmaceutical and biotechnology companies so as to leverage these companies' comparative advantage in clinical and regulatory development as well as in sales and marketing. This approach has enabled Flamel to leverage its technology platforms to develop a maximum number of projects in development across a wide variety of molecules and indications with a diversified group of named and unnamed partner companies. Flamel Technologies is French société anonyme that is listed exclusively on the Nasdaq under the symbol FLML.

Flamel has partnership agreements with major pharmaceutical companies:

BioNetwork 2010 Conference attendance
BioNetwork is dedicated to advancing breakthrough partnerships between pharmaceutical and biotech companies. The event is produced by Worldwide Business Research and will be held at the Ritz Carlton, Laguna Niguel, CA on October 25-27, 2010.

Flamel Technologies Corporate Presentation - July 2010
To view the latest presentation, click here.

Latest News:
July 28, 2010
Flamel Technologies Announces Three New Partnership Agreements; Second Quarter 2010 Results